Back to First Eagle Investment Management, LLC First Eagle Investment Management, LLC

HALOHALO

Showing 0 of 9 quarters

Position history for First Eagle Investment Management, LLCFirst Eagle Investment Management, LLC's holdings in HALOZYME THERAPEUTICS INC

No. First Eagle Investment Management exited its HALO (Halozyme Therapeutics) position in Q4 2020. Its Q3 2020 13F listed 483,800 shares worth $12.7M. First Eagle Investment Management already held HALO in its Q4 2018 13F, the earliest on record, and held it in 8 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used